U.S. stocks move: 10x Genomics surged on October 9th due to target price upgrade, Fred Hutchinson collaboration, and spatial genomics.
Bitget异动解读2026/10/09 14:0510x Genomics October 9th Surge Analysis
Keywords: Target Price Raise, Fred Collaboration, Spatial Omics
1. On October 9th, BofA Securities raised the target price for 10x Genomics from $50 to $80 and maintained a hold rating.
2. On October 7th, the company reached a multi-project research collaboration with Fred Hutchinson Cancer Center, utilizing the Flex Apex, Xenium, and upcoming Atera platforms to conduct biomarker discovery in bladder cancer and minimal residual disease detection in acute myeloid leukemia, driving the application of single-cell and spatial technologies into clinical research of solid tumors and hematologic malignancies.
(Disclaimer: This content is generated by AI technology based on public information summary, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Societe Generale lowers Tesla's target price to $266
Société Générale has lowered the Tesla (TSLA.US) target price from $268 to $266.
US Stock Movement | Pony.ai (PONY.US) rises over 5%, seventh-generation Robotaxi to be introduced in London, UK
According to Zhihu Finance App, PONY.AI (PONY.US) rose over 5% on Friday, closing at $6.07. The news comes as, on October 8, autonomous driving company PONY.AI and global mobility platform Uber announced that they are moving forward with the introduction of PONY.AI's seventh-generation Robotaxi in London, UK, with road testing expected to officially begin in the coming weeks. London will become another key city in the companies' strategy for large-scale Robotaxi deployment in Europe.
Crypto prices
More
